focus -WSS

focus

author：hotspot 2025-09-29 16:45:21 - browse：85

Scientist Nour Tabidi prepares a DNA sample in a lab. -- health coverage from STAT — Scientist Nour Tabidi prepares a DNA sample in a lab at Thermo Fisher's recently opened manufacturing plant in Plainville. John Tlumacki/Globe Staff

Thermo Fisher Scientific’s giant plant to manufacture gene therapies for drug companies is barely a year old, but executives at the maker of scientific tools are already talking about expanding.

Standing inside a cavernous unfinished section of the plant, Paul Fitzgerald, vice president and general manager of the site, told a group of biotech executives, journalists, and other visitors that he’s eager to transform it into laboratories. So far, the company is only using about 290,000 of the plant’s more than 400,000 square feet.

“I look forward to you guys giving us a reason to fill up this space,” Fitzgerald quipped during a tour Tuesday of the plant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Readout Newsletter: Amylyx, Aurinia, and IQVIA

WSS

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Too many hospitalized Covid

States should stop sabotaging methadone treatment reform

Eli Lilly reports tirzepatide MASH success during Q4 earnings

AMAs digital advisors table RPM coding reform proposal, again

Ebola vaccine can save some who are already sick, per new study

hotspot

focus

entertainment

New air purifier tech could be key to improving indoor air quality

States should stop sabotaging methadone treatment reform

Wildfire smoke exposes gaps in outdoor worker protections

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Medical records are filled with copy

Food as medicine: Medically tailored meals may get standardized

Peter Hotez and the public health issue of online harassment

Roche subsidiary Foundation Medicine opens new headquarters

At least 13 dead in Texas as scorching temps continue

Washington mulls new rules to avert another Change Healthcare

hotspot

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Resistance to opioid

Report cites 'urgent' need to recruit more diverse clinical trial participants

There's no autism epidemic. It's an autism diagnosis epidemic

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Congress considering partial increase for doctor pay in Medicare

explore

hotspot

hotspot

hotspot